First-in-Class Vepdegestrant Approved in Advanced Breast Cancer

(MedPage Today) — The FDA has approved oral vepdegestant (Veppanu) for adults with estrogen receptor (ER)-positive/HER2-negative advanced or metastatic breast cancer, the agency announced Friday. Approval of the first proteolysis targeting…